UY25827A1 - Derivados de higromicina utiles en el tratamiento de infecciones - Google Patents

Derivados de higromicina utiles en el tratamiento de infecciones

Info

Publication number
UY25827A1
UY25827A1 UY25827A UY25827A UY25827A1 UY 25827 A1 UY25827 A1 UY 25827A1 UY 25827 A UY25827 A UY 25827A UY 25827 A UY25827 A UY 25827A UY 25827 A1 UY25827 A1 UY 25827A1
Authority
UY
Uruguay
Prior art keywords
alkyl
compounds
treatment
infections
halo
Prior art date
Application number
UY25827A
Other languages
English (en)
Inventor
Matthew Nerrill Hayward
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY25827A1 publication Critical patent/UY25827A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula I, útiles en el tratamiento de infecciones bacterianas y protozoarias en mamíferos, aves y peces. Son útiles contra bacterias gram positivas y negativas. La adición de dietilaminopiridina y trietilamina a la reacción puede ser ventajosa. La actividad antibacteriana de los co,puestos de la presente invención contra patógenos bacterianos se demuestra por la capacidad de los compuestos de inhibir el crecimiento de cepas de patógenos definidas. El compuesto de fórmula (I), donde X1 es -CR6R7-, -S(O)n, en la que n es de 0 a 2, -NR6, etc; R1 es H u OH; R2 es H, alquilo C16 o halo, donde el grupo alquilo esta sustituído por 1 ó 2 gripos R4 o cuando X2 es -NR6-, entonces R3 y X2 pueden tomarseconjuntamente para formar un anillo de 5 a12 miembros; R3 se selecciona se H, alquilo C1-10, etc; R4 es alquilo C1-10, alquenilo, halo, ciano, nitro, azido, hidroxi, etc; R6 y R7 es H, alquilo, fluor, etc.
UY25827A 1998-12-02 1999-11-30 Derivados de higromicina utiles en el tratamiento de infecciones UY25827A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11061898P 1998-12-02 1998-12-02

Publications (1)

Publication Number Publication Date
UY25827A1 true UY25827A1 (es) 2001-08-27

Family

ID=22334003

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25827A UY25827A1 (es) 1998-12-02 1999-11-30 Derivados de higromicina utiles en el tratamiento de infecciones

Country Status (38)

Country Link
US (1) US6245745B1 (es)
EP (1) EP1135400A1 (es)
JP (1) JP3393189B2 (es)
KR (1) KR100418167B1 (es)
CN (1) CN1329617A (es)
AP (1) AP2001002154A0 (es)
AR (1) AR019784A1 (es)
AU (1) AU6362799A (es)
BG (1) BG105645A (es)
BR (1) BR9915813A (es)
CA (1) CA2352332C (es)
CO (1) CO5150171A1 (es)
CZ (1) CZ20011904A3 (es)
DZ (1) DZ2932A1 (es)
EA (1) EA004303B1 (es)
EE (1) EE200100301A (es)
GE (1) GEP20033144B (es)
GT (1) GT199900205A (es)
HN (1) HN1999000202A (es)
HR (1) HRP20010413A2 (es)
HU (1) HUP0104949A3 (es)
ID (1) ID28848A (es)
IL (1) IL142882A0 (es)
IS (1) IS5930A (es)
MA (1) MA26705A1 (es)
NO (1) NO20012687D0 (es)
NZ (1) NZ511424A (es)
OA (1) OA11721A (es)
PA (1) PA8486101A1 (es)
PE (1) PE20001429A1 (es)
PL (1) PL348063A1 (es)
SK (1) SK7302001A3 (es)
TN (1) TNSN99211A1 (es)
TR (1) TR200101540T2 (es)
UY (1) UY25827A1 (es)
WO (1) WO2000032616A1 (es)
YU (1) YU32601A (es)
ZA (1) ZA200104434B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2389019A1 (en) * 1999-10-29 2001-05-03 Pfizer Products Inc. Hygromycin a prodrugs
EP1224197A1 (en) * 1999-10-29 2002-07-24 Pfizer Products Inc. Hygromycin derivatives
EA200201167A1 (ru) 2000-06-02 2003-06-26 Пфайзер Продактс Инк. Производные гигромицина а для лечения бактериальных и протозойных инфекций
EP1643901A4 (en) * 2003-06-19 2008-10-29 Compumed Inc METHOD AND SYSTEM FOR ANALYZING BONE CONDITIONS USING A RADIOGRAPHIC IMAGE OF COMPATIBLE DICOM OS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL344521A1 (en) * 1998-05-04 2001-11-05 Pfizer Prod Inc Hygromycin a derivatives
AU762302B2 (en) * 1998-05-04 2003-06-19 Pfizer Products Inc. 2"-deoxy hygromycin derivatives

Also Published As

Publication number Publication date
EP1135400A1 (en) 2001-09-26
NO20012687L (no) 2001-05-31
BR9915813A (pt) 2001-08-21
CN1329617A (zh) 2002-01-02
OA11721A (en) 2005-01-25
IL142882A0 (en) 2002-03-10
NZ511424A (en) 2003-08-29
US6245745B1 (en) 2001-06-12
PE20001429A1 (es) 2000-12-18
YU32601A (sh) 2004-05-12
BG105645A (bg) 2002-02-28
GEP20033144B (en) 2003-12-25
TNSN99211A1 (fr) 2005-11-10
TR200101540T2 (tr) 2001-10-22
HRP20010413A2 (en) 2002-06-30
KR20010093136A (ko) 2001-10-27
HUP0104949A2 (hu) 2002-04-29
AR019784A1 (es) 2002-03-13
AP2001002154A0 (en) 2001-05-09
EE200100301A (et) 2002-08-15
GT199900205A (es) 2001-05-24
ID28848A (id) 2001-07-05
CA2352332C (en) 2004-12-07
PL348063A1 (en) 2002-05-06
AU6362799A (en) 2000-06-19
HUP0104949A3 (en) 2003-12-29
EA200100444A1 (ru) 2001-10-22
EA004303B1 (ru) 2004-02-26
CZ20011904A3 (cs) 2001-10-17
IS5930A (is) 2001-04-27
ZA200104434B (en) 2002-05-30
NO20012687D0 (no) 2001-05-31
CO5150171A1 (es) 2002-04-29
KR100418167B1 (ko) 2004-02-11
DZ2932A1 (fr) 2004-03-15
HN1999000202A (es) 2000-06-13
MA26705A1 (fr) 2004-12-20
PA8486101A1 (es) 2000-09-29
WO2000032616A1 (en) 2000-06-08
JP3393189B2 (ja) 2003-04-07
JP2002531463A (ja) 2002-09-24
CA2352332A1 (en) 2000-06-08
SK7302001A3 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
PE20000049A1 (es) Nuevos macrolidos
GB0015876D0 (en) Organic compounds
ES2103249T1 (es) Procedimiento y composicion para inhibir el crecimiento de microorganismos incluyendo acido peracetico y un biocida no oxidante.
HN1998000073A (es) Derivados de la 9 - oxima eritromicina
MY139244A (en) 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole
MA28296A1 (fr) Composes synthetiques utiles comme agents de nodulation des legumineuses et procedes de preparation de ces composes
BRPI0413372A (pt) composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos
DK0667866T3 (da) 1,4-benzothiazepiner anvendelige som neurologiske midler
KR940703923A (ko) 4,5-디히드로겔다나마이신 및 그의 하이드로퀴논의 제조 방법 및 용도(Process and Uses for 4,5-Dihydrogeldanamycin and Its Hydroquinone)
KR880010671A (ko) 살균 조성물 및 이의 용도
KR970705392A (ko) 신규한 항생제 조성물 및 그람-양성 세균 및 마이코플라스마 감염의 치료 방법(novel antibiotic compounds and methods to treat grampositive bacterial and mycoplasmal infections)
HK1030373A1 (en) Oxazolidinone derivatives and pharmaceutical compositions.
UY25827A1 (es) Derivados de higromicina utiles en el tratamiento de infecciones
PE99098A1 (es) Derivados de 14-o-carbamoilo de mutilina
ES2051652A6 (es) Procedimiento para la preparacion de compuestos inhibidores de fosfolipasa a2
MY128739A (en) Compositions and methods for treating bacterial infections
EA200200758A1 (ru) Способ получения 5-цианофталида
EP1211259A4 (en) ANTIBIOTIC CAPRAZAMYCINS AND METHOD FOR THE PRODUCTION THEREOF
RU95104884A (ru) 13-замещенные производные милбемицинов, антигельминтная акарицидная и инсектицидная композиция, способ защиты растений
PE20060619A1 (es) Derivados de oxazolidinona como antibacterianos
AP2001002168A0 (en) Organo-phosphorus compounds and their utilization.
PE20000474A1 (es) Inhibidores de la oxido nitrico sintasa
MA21960A1 (fr) Preparation de 9 -(2,2-dicarboalcoxycyclopropylpurine .
AU2118900A (en) Antibacterial hydroxamic acid derivatives
AR009349A1 (es) Un procedimiento para preparar paclitaxel, un derivado de taxano y un derivado de oxazolidina utilizables como intermediarios y procedimientos para prepararlos.

Legal Events

Date Code Title Description
ABAN Application deemed to be withdrawn (no publication fee paid)

Effective date: 20081211